FindTrial
Sign In

To study the comparative effect of pathyadi churna and avipattikar churna in the management of amlapitta.

A randomized parallel arm comparative clinical study to evaluate the efficacy of pathyadi churna and avipattikar churna in the management of amlapitta. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064297
Enrollment
110
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

Dr Samarth Kasliwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants between Age group -18-60 years 2) Participants irrespective of age,sex,caste,religion 3) Participants presenting with primary classical features of the Amlapitta with 1 or more secondary features will be selected

Exclusion criteria

Exclusion criteria: 1) Pregnant & lactating mothers. 2) Participants on NSAIDs. 3) Participants on long term steroids (for more than 6 months) 4) Known case of Intestinal TB, CA Stomach. 5) Known case of DM, Kidney diseases, Hepatobiliary diseases and Ulcerative colitis

Design outcomes

Primary

MeasureTime frame
To determine the effect of pathyadi churna in the management of amlapitta.Timepoint: 21 days—

Secondary

MeasureTime frame
1)To study Safety of pathyadi churna & avipattikar churna in the management of amlapitta. 2)To understand in detail Samprapti of AmlapittaTimepoint: 21 days—

Countries

India

Contacts

Public ContactDr Samarth Kasliwal

Seth Govindji Raoji Ayurved Mahavidhyalaya

channamma.hiremath@sgrayurved.edu.in7756977095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026